Exhibit 10.29

EMPLOYMENT AGREEMENT

THIS AGREEMENT is dated effective January 1, 2009, by and among APP
Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Richard E. Maroun
(the “Executive”) and, solely for the purposes of guaranteeing the Company’s
obligations under Section 5 of this Agreement, Fresenius SE, a societas europaea
organized under the laws of Germany (the “Parent”).

WHEREAS, on September 10, 2008 the Company became an indirect subsidiary of the
Parent;

WHEREAS, the Company desires to have the Executive continue to serve as the
Company’s Executive Vice President/General Counsel, on the terms and conditions
set forth in this Agreement;

WHEREAS, the Executive desires to accept such service, subject to the terms and
conditions of this Agreement and;

WHEREAS, this Agreement shall wholly-replace and supersede the Retention
Agreement, dated May 23, 2008 in its entirety.

NOW, THEREFORE, in consideration of the premises and mutual covenants contained
herein and for other good and valuable consideration, the receipt and
sufficiency of which is mutually acknowledged, the Company and the Executive
(individually, a “Party” and together, the “Parties”) agree as follows:

1. Effective Date. The “Effective Date” shall mean January 1, 2009.

2. Employment Period. The Company hereby agrees to continue to employ the
Executive, and the Executive hereby agrees to continue to be employed by the
Company, subject to the terms and conditions of this Agreement, for a period
commencing on the Effective Date and ending on December 31, 2011, unless earlier
terminated as provided for herein. Notwithstanding the foregoing, commencing on
January 1, 2012 and each January 1 thereafter (each, deemed an “Extension
Effective Date”), the term of this Agreement shall be extended, without further
action by the Company or the Executive, for successive periods of twelve
(12) months each, unless either Party shall have given nine (9) months’ advance
notice to the other Party, in the manner set forth in Section 8(b) below, prior
to the Extension Effective Date in question (that is, no later than April 1,
2011, etc.), that the term of this Agreement that is in effect at the time such
notice is given is not to be extended or further extended, as the case may be
(the period of such employment to be called the “Employment Period”).

3. Terms of Employment.

(a) Position and Duties.

(i) During the Employment Period, the Executive shall serve as the General
Counsel of the Company, with such duties and responsibilities as are

--------------------------------------------------------------------------------

commensurate with such position, and shall report directly to the Chief
Executive Officer of the Company. The Executive’s principal location of
employment shall be Los Angeles, California; provided, however, that the
Executive will be required under reasonable business circumstances to travel
outside of the principal location of employment in connection with performing
his duties under this Agreement. It is expected that Executive will spend not
more than 50% of his working time in the principal headquarters of the Company
in Schaumburg, Illinois or attending to Company business in locations other than
Los Angeles, California unless otherwise agreed to by Executive and the Chief
Executive Officer of the Company.

(ii) The Executive agrees that during the Employment Period, he shall devote all
of his business time, energies and talents to serving as the Company’s General
Counsel, and shall perform his duties conscientiously and faithfully subject to
the lawful directions of the Chief Executive Officer of the Company, and in
accordance with each of the corporate governance and ethics guidelines, conflict
of interests policies, and codes of conduct of the Company. The Company
acknowledges that Executive served as General Counsel and CAO for Abraxis
Bioscience, Inc. (“Abraxis”), and since the separation of Abraxis and Company
Executive has performed certain services under the Transition Services Agreement
dated November 13, 2007 and entered into between Abraxis and Company. The
Company agrees that Executive may continue to perform such services under the
Transition Services Agreement through June 30, 2009.

(iii) Except as set forth in Section 3(a)(ii) and on Schedule 3(a)(iii), during
the Employment Period, the Executive shall not, without the prior written
consent of the Chief Executive Officer of the Company: (A) render or perform
services of a business, professional or commercial nature other than to or for
the Company or any of its affiliates or subsidiaries, either alone or as an
employee, consultant, director, officer or partner of another business entity
(including serving on boards of directors), whether or not for compensation or
(B) plan or otherwise take any preliminary steps, either alone or in concert
with others, to establish or engage in any business activity that would compete
with the current or proposed businesses of the Company or any of its affiliates
or subsidiaries.

(a) Compensation.

(i) Base Salary. As compensation for the performance by the Executive of his
obligations hereunder, during the Employment Period, the Company shall pay the
Executive a base salary at an annual rate of $480,000 (the “Base Salary”). The
Base Salary shall be payable in accordance with the Company’s regularly
established payroll practice. The Company shall conduct an annual review of the
Base Salary and may increase (but not decrease) such Base Salary in its sole
discretion, based on the performance of the Executive and the Company.

(ii) Annual Bonus. With respect to each calendar year during the Employment
Period the Executive shall receive a cash bonus of up to $780,000, based on the
achievement of the Company EBITDA targets set forth on Exhibit A

 

- 2 -

--------------------------------------------------------------------------------

to this Agreement (the “Annual Bonus”) and payable in a single lump sum cash
payment not later than March 15 following the conclusion of the calendar year in
which the Annual Bonus is earned.

(iii) Vacation. During the Employment Period, the Executive shall be entitled to
four (4) weeks of paid vacation for each calendar year or pro-ratable part
thereof. In addition, the Executive shall be entitled to all paid holidays
typically granted to executive officers of the Company generally.

(iv) Benefits and Perquisites. The Executive shall be entitled to participate on
a comparable basis in all employee benefit plans and to all perquisites which
shall be made available from time-to-time to executive officers of the Company
generally (including, but not limited to, equity-based and other long-term
incentive plans, qualified and non-qualified retirement and deferred
compensation plans, medical, dental and other welfare plans, and executive
short-term disability insurance, and executive long-term disability insurance
and supplemental income protection, health club reimbursement, estate and
financial planning services and supplemental life insurance). The Executive
acknowledges and agrees that the Company may, in its discretion, terminate at
any time or modify from time-to-time any such employee benefit plans or
perquisites for any and all beneficiaries thereof.

(v) Company Automobile Lease. The Executive shall be entitled to an automobile
lease allowance during the Employment Period at the Company’s expense in an
amount of $1,000 per month.

(vi) Expenses. During the Employment Period, the Executive shall be eligible for
prompt reimbursement for business expenses reasonably incurred by the Executive
in accordance with the policies of the Company as may be in effect from
time-to-time for executive officers of the Company generally.

4. Termination of Employment.

(a) Death. The Executive’s employment shall terminate automatically upon the
Executive’s death during the Employment Period.

(b) Disability. If the Executive experiences a Disability (within the meaning of
the applicable disability plan, program or arrangement of the Company, as in
effect from time to time) during the Employment Period, the Company may provide
the Executive with a Notice of Termination in accordance with Section 4(f) below
of its intention to terminate the Executive’s employment. In such event, the
Executive’s employment with the Company shall terminate immediately upon the
receipt of such Notice of Termination by the Executive.

(c) Cause. The Executive’s employment may be terminated by the Company during
the Employment Period other than for Cause upon the Company providing a Notice
of Termination to the Executive of its intention to so terminate the Executive’s
employment in accordance with Section 4(f) below. The Executive’s

 

- 3 -

--------------------------------------------------------------------------------

employment may be terminated by the Company for Cause if: (A) the Company
provides the Executive with a Notice of Termination in accordance with
Section 4(f) of this Agreement within thirty (30) days after the Company’s
discovery of the occurrence or existence of an event or circumstance set forth
in this Section 4(c), which notice shall specifically identify the event or
circumstance that the Company believes constitutes Cause and (B) the Executive
fails to correct the circumstance or event so identified within 60 days after
the receipt of such notice. For purposes of this Agreement, “Cause” shall mean:

(i) the Executive’s dishonesty, willful misconduct or gross negligence in the
performance of his duties to or for the Company or any of its affiliates or
subsidiaries;

(ii) the Executive’s willful material misrepresentation at any time to or on
behalf of the Company or any of its affiliates or subsidiaries;

(iii) the Executive’s intentional failure or refusal to perform his reasonably
assigned duties;

(iv) the Executive’s commission of any felony, or any other crime (whether or
not a felony) involving dishonesty, fraud or breach of trust;

(v) the Executive’s willful or grossly negligent failure to comply with any
written rules, regulations, policies or procedures of the Company or any of its
affiliates or subsidiaries; or

(vi) the Executive’s material breach of the provisions of Section 6 of this
Agreement.

(d) Good Reason. The Executive’s employment may be voluntarily terminated by the
Executive with Good Reason if: (A) an event or circumstance set forth in the
clauses of this Section 4(d) below shall have occurred and the Executive
provides the Company with a Notice of Termination in accordance with
Section 4(f) below within thirty (30) days after the Executive has knowledge of
the initial occurrence or existence of such event or circumstance, which notice
shall specifically identify the event or circumstance that the Executive
believes constitutes Good Reason and (B) the Company fails to correct the
circumstance or event so identified within thirty (30) days after the receipt of
such notice.

For purposes of this Agreement, “Good Reason” shall mean, without the
Executive’s express written consent, the occurrence of any of the following
circumstances:

(i) There is a reduction in the Executive’s status or responsibilities which
represents a material and adverse change from the Executive’s overall status or
responsibilities, taken as a whole, in reference to the status or
responsibilities contemplated by Section 3(a);

 

- 4 -

--------------------------------------------------------------------------------

(ii) The Executive is required to be based at any place outside of fifty
(50) mile radius from Los Angeles, California without his written consent,
except for travel which is reasonably necessary in connection with the Company’s
business or his responsibilities;

(iii) Any material breach of the Agreement by the Company, including but not
limited to, the failure to pay or provide compensation and benefits in
accordance with Section 3 (b) hereof;

(iv) Delivery by the Company of a notice of non-extension pursuant to Section 2;
or

(v) Any failure by the Successor (as defined in Section 8(j) below) to assume
and agree to perform the Company’s obligations hereunder.

(e) Voluntary Termination. The Executive may voluntarily terminate his
employment under this Agreement without Good Reason by providing a Notice of
Termination to the Company of his intention to so terminate his employment in
accordance with Section 4(f) below. Such termination shall not be deemed to be a
breach of this Agreement.

(f) Notice of Termination. Any termination of the Executive’s employment by the
Company or by the Executive (other than death) shall be communicated by a
written notice (“Notice of Termination”) to the other Party hereto in accordance
with Section 8(b) below. The “Date of Termination” shall mean:

(i) if the Executive’s employment is terminated by the Executive’s death, the
date of his death,

(ii) if the Executive’s employment is terminated by the Company for Cause or
Disability, the date specified in the Notice of Termination and

(iii) if the Executive’s employment is terminated under any circumstances other
than those described in clause (i) or (ii) immediately preceding, the date
specified in the Notice of Termination which shall not be less than ninety
(90) days from the date such Notice of Termination is given.

(g) Resignation from All Positions. Notwithstanding any other provision of this
Agreement, upon the termination of the Executive’s employment for any reason,
unless otherwise requested by the Company, the Executive shall immediately
resign from all positions which he holds or has ever held with the Company or
any of its affiliates or subsidiaries (and with any other entities with respect
to which the Company has requested the Executive to perform services). The
Executive hereby agrees to execute any and all documentation to effectuate such
resignations upon request of the Company, but he shall be treated for all
purposes as having so resigned upon the Date of Termination, regardless of when
or whether he executes any such documentation.

 

- 5 -

--------------------------------------------------------------------------------

5. Obligations of the Company upon Termination.

(a) Good Reason; Other Than for Cause. If during the Employment Period, (A) the
Company shall terminate the Executive’s employment other than for Cause, death
or Disability or (B) the Executive shall terminate employment with Good Reason:

(i) the Company shall pay to the Executive no later than the next regularly
scheduled paycheck after the Date of Termination, (or for any Annual Bonus
portion, as soon thereafter as it can be calculated with reasonable certainty
and only as to that portion), the sum of the Executive’s: (i) accrued but unpaid
Base Salary; (ii) accrued but unused Vacation time; (iii) any other accrued but
unpaid perquisites; (iv) any accrued but unpaid Annual Bonus through the Date of
Termination, to the extent not previously paid; and (v) the Executive’s business
expenses deemed reimbursable pursuant to Section 3(b)(vi), but which have not
yet been reimbursed by the Company as of the Date of Termination (collectively,
the “Obligations”);

(ii) the Company shall pay to the Executive an amount equal to the sum of:
(A) eighteen (18) months of the Executive’s then-current annual Base Salary at
the highest rate in effect during the twelve (12) month period immediately
preceding the Date of Termination and (B) fifty percent (50%) of the Annual
Bonus paid or payable to the Executive for the most recently completed calendar
year. The amount shall be paid in substantially equal installments in accordance
with the Company’s regularly established payroll practice during the twelve
(12) month period immediately following the Date of Termination;

(iii) the Company shall continue to provide the benefits to the Executive
(medical, dental, prescription drug only) during the eighteen (18) month period
immediately following the Date of Termination;

(iv) the Company shall continue to provide Executive’s automobile lease
allowance during the eighteen (18) month period immediately following the Date
of Termination or until the expiration of this Agreement on December 31, 2011,
whichever occurs first; and

(v) to the extent not theretofore paid or provided, the Company shall timely pay
or provide to the Executive any other amounts or benefits required to be paid or
provided or which the Executive is eligible to receive under any plan, program,
policy or practice, contract or agreement, including all accrued but unused
vacation (other than any severance plan, program, policy or practice, contract
or agreement) of the Company and its affiliates and subsidiaries (such amounts
and benefits, the “Other Benefits”) in accordance with the terms and normal
procedures of each such plan, program, policy or practice, contract or
agreement, based on accrued benefits through the Date of Termination.

(vi) Except with respect to payments and benefits under Sections 5(a)(i) and
5(a)(iv), all payments and benefits to be provided under this Section 5(a) shall
be subject to the Executive’s execution and non-revocation of a general release
of claims in favor of the Company and its affiliates and subsidiaries.

 

- 6 -

--------------------------------------------------------------------------------

(b) Cause; Other than for Good Reason. If the Executive’s employment shall be
terminated for Cause or if the Executive terminates his employment without Good
Reason during the Employment Period, this Agreement shall terminate without
further obligation(s) to the Executive, other than the obligation to pay or
provide to the Executive the Obligations and the timely payment or provision of
the Other Benefits.

(c) Death. If the Executive’s employment is terminated by reason of the
Executive’s death during the Employment Period, this Agreement shall terminate
without further obligations to the Executive’s legal representatives, other than
the obligation to pay or provide to the Executive’s beneficiaries the
Obligations and the timely payment or provision of the Other Benefits.

(d) Disability. If the Executive’s employment is terminated by reason of the
Executive’s Disability during the Employment Period, this Agreement shall
terminate without further obligations to the Executive, other than the
obligation to pay or provide to the Executive the Obligations and the timely
payment or provision of the Other Benefits, including any applicable disability
benefits.

6. Unauthorized Disclosure; Non-Solicitation; Non-Competition; Proprietary
Rights.

(a) Unauthorized Disclosure and Use. The Executive agrees and understands that
in the Executive’s position with the Company, the Executive has been and will be
exposed to and has and will receive information relating to the confidential
affairs of the Company, including, without limitation, technical information,
intellectual property, business and marketing plans, strategies, customer
information, software, other information concerning the products, promotions,
development, financing, expansion plans, business policies and practices of the
Company and other forms of information considered by the Company to be
confidential and in the nature of trade secrets (including, without limitation,
ideas, research and development, know-how, formulas, technical data, designs,
drawings, specifications, customer and supplier lists, pricing and cost
information and business and marketing plans and proposals) (collectively, the
“Confidential Information”); provided, however, that information that is or
becomes generally available to the public other than as a result of a breach of
this Agreement by the Executive shall not be considered to be Confidential
Information.

The Executive agrees that at all times during the Executive’s employment with
the Company and thereafter, the Executive shall not disclose such Confidential
Information, either directly or indirectly, to any individual, corporation,
partnership, limited liability company, association, trust or other entity or
organization, including a government or political subdivision or an agency or
instrumentality thereof (each, a “Person”) without the prior written consent of
the Company and shall not use or attempt to use any such information in any
manner other than in connection with his employment with the Company, unless
required by law to disclose such information, in which case the

 

- 7 -

--------------------------------------------------------------------------------

Executive shall provide the Company with written notice in accordance with
Section 8(b) below of such requirement as far in advance of such anticipated
disclosure as possible so as to enable the Company to seek an appropriate
protective order or confidential treatment.

This confidentiality covenant has no temporal, geographical or territorial
restriction. Upon termination of the Executive’s employment with the Company,
the Executive shall promptly return to the Company all property, keys, notes,
memoranda, writings, lists, files, reports, customer lists, correspondence,
tapes, disks, cards, surveys, maps, logs, machines, technical data and any other
tangible product or document which has been produced by, received by or
otherwise submitted to the Executive during or prior to the Executive’s
employment with the Company, and any copies thereof in his (or capable of being
reduced to his) possession.

(b) Non-Competition. By and in consideration of the Company’s entering into this
Agreement and the payments to be made and benefits to be provided by the Company
hereunder, and in further consideration of the Executive’s exposure to the
Confidential Information of the Company, the Executive agrees that the Executive
shall not, during the Executive’s employment with the Company and for a
twelve-month period following the Date of Termination (the “Restriction
Period”), directly or indirectly, own, manage, operate, join, control, be
employed by, or participate in the ownership, management, operation or control
of, or be connected in any manner with, including, without limitation, holding
any position as a stockholder, director, officer, consultant, independent
contractor, employee, partner, or investor in, any Restricted Enterprise (as
defined below); provided, however, that in no event (A) shall ownership by the
Executive of five percent (5%) or less of the outstanding securities of any
class of any issuer whose securities are registered under the Securities
Exchange Act of 1934, as amended, standing alone, be prohibited by this
Section 6(b), so long as the Executive does not have, or exercise, any rights to
manage or operate the business of such issuer other than rights as a stockholder
thereof, nor (B) shall being employed by a Person that is a Restricted
Enterprise, standing alone, be prohibited by this Section 6(b), so long as
(i) such Person has more than one discrete and readily distinguishable part of
its business, (ii) the Executive’s duties are not at or involving the part of
such Person that is the Restricted Enterprise, including, without limitation,
serving in a capacity where any Person involved in the Restricted Enterprise
reports to the Executive and (iii) the Executive notifies the Company of
employment with such Person prior to commencement of his or her employment with
such Person.

For purposes of this Section 6(b), “Restricted Enterprise” shall mean any Person
that is engaged, directly or indirectly, in (or intends or proposes to engage
in, or has been organized for the purpose of engaging in) the generic injectable
pharmaceutical industry. During the twelve-month period following the Date of
Termination, upon the request of the Company, the Executive shall notify the
Company of the Executive’s then-current employment status.

(c) Non-Solicitation of Employees. During Executive’s employment with the
Company and for a twelve (12) month period following the Date of Termination,
the Executive shall not directly or indirectly contact, induce or solicit (or
assist any Person to contact, induce or solicit) for employment or consulting
services any person who is, or within twelve (12) months prior to the date of
such solicitation was, an employee or consultant of the Company.

 

- 8 -

--------------------------------------------------------------------------------

(d) Non-Solicitation of Customers. During the Restriction Period, the Executive
shall not (A) contact, induce or solicit (or assist any Person to contact,
induce or solicit) any Person which has a business relationship with the Company
to terminate, curtail or otherwise limit such business relationship, or
(B) solicit, other than on behalf of the Company, any Person that the Executive
knows or should have known (i) is a current customer of the Company, (ii) was,
within twelve months prior to the date of such solicitation, a customer of the
Company or (iii) is a Person with respect to which the Company has, within the
twelve months prior to the date of such solicitation, devoted more than de
minimis resources in an effort to cause such Person to become a customer of the
Company.

(e) Proprietary Rights. The Executive shall disclose promptly to the Company any
and all inventions, discoveries, and improvements (whether or not patentable or
registrable under copyright or similar statutes), and all patentable or
copyrightable works, initiated, conceived, discovered, reduced to practice, or
made by him, either alone or in conjunction with others, during the Executive’s
employment with the Company and related to the business or activities of the
Company (the “Developments”).

Except to the extent any rights in any Developments constitute a work made for
hire under the U.S. Copyright Act, 17 U.S.C. § 101 et seq., that are owned ab
initio by the Company, the Executive assigns, to the maximum extent permitted by
California Labor Code section 2870, all of his right, title and interest in and
to all Developments (including all intellectual property rights therein) to the
Company or its nominee without further compensation, including all rights or
benefits therefore, including without limitation the right to sue and recover
for past and future infringement. The Executive acknowledges that any rights in
any developments constituting a work made for hire under the U.S. Copyright Act,
17 U.S.C § 101 et seq., are owned upon creation by the Company as the
Executive’s employer. Whenever requested to do so by the Company, the Executive
shall execute any and all applications, assignments or other instruments which
the Company shall deem necessary to apply for and obtain trademarks, patents or
copyrights of the United States or any foreign country or otherwise protect the
interests of the Company therein. These obligations shall continue beyond the
end of the Executive’s employment with the Company, with respect to inventions,
discoveries, improvements or copyrightable works initiated, conceived or made by
the Executive while employed by the Company, and shall be binding upon the
Executive’s employers, assigns, executors, administrators and other legal
representatives.

In connection with his execution of this Agreement, the Executive has informed
the Company in writing of any interest in any inventions or intellectual
property rights that he holds as of the date hereof. If the Company is unable
for any reason, after reasonable effort, to obtain the Executive’s signature on
any document needed in connection with the actions described in this
Section 6(d), the Executive hereby irrevocably designates and appoints the
Company and its duly authorized officers and

 

- 9 -

--------------------------------------------------------------------------------

agents as the Executive’s agent and attorney in fact to act for and in the
Executive’s behalf to execute, verify and file any such documents and to do all
other lawfully permitted acts to further the purposes of this section with the
same legal force and effect as if executed by the Executive.

(f) Remedies. The Executive agrees that any breach of the terms of this
Section 6 would result in irreparable injury and damage to the Company for which
the Company would have no adequate remedy at law; the Executive therefore also
agrees that in the event of such breach or any threat of breach, the Company
shall be entitled to an immediate injunction and restraining order to prevent
such breach and/or threatened breach and/or continued breach by the Executive
and/or any and all Persons acting for and/or with the Executive, without having
to prove damages, in addition to any other remedies to which the Company may be
entitled at law or in equity, including, without limitation, the obligation of
the Executive to return to the Company any portion of severance payments that
have been paid to him. The terms of this paragraph shall not prevent the Company
from pursuing any other available remedies for any breach or threatened breach
hereof, including, without limitation, the recovery of damages from the
Executive. The Executive and the Company further agree that the provisions of
the covenants contained in this Section 6 are reasonable and necessary to
protect the businesses of the Company because of the Executive’s access to
Confidential Information and his material participation in the operation of such
businesses.

(g) Definition of Company. For purposes of this Section 6, the “Company,” as
used above, shall be construed to include the Company and its Parent,
subsidiaries and affiliates.

(h) Survival. The provisions of this Section 6 shall survive the termination of
the Executive’s employment with the Company, regardless of the reason for such
termination, for the duration expressly stated in any such provision or, if no
duration is stated, then indefinitely.

7. Assignment. This Agreement, and the Executive’s rights and obligations
hereunder, may not be assigned by the Executive, and any purported assignment by
the Executive in violation hereof shall be null and void. The Company may,
without the consent of the Executive, assign this Agreement to any entity that
is a successor to: (a) all or substantially all of the business and/or assets of
the Company or (b) that portion of the business and/or assets of the Company to
which the Executive’s services relate.

For purposes of this Agreement, (i) any reference to “the Company” herein shall
be deemed to be a reference to any such successor of the Company and (ii) no
transfer of the Executive’s employment which occurs in connection with any event
that results in such a successor shall be deemed to be a termination of the
Executive’s employment for any purpose under this Agreement or otherwise.

8. Miscellaneous.

(a) Governing Law. This Agreement shall be construed and enforced in accordance
with, and the rights and obligations of the parties hereto shall be governed by,
the laws of the State of Illinois, without giving effect to the conflicts of law
principles thereof.

 

- 10 -

--------------------------------------------------------------------------------

(b) Notices. All notices, claims, certificates, requests, demands and other
communications hereunder shall be in writing and shall be deemed to have been
duly given and delivered if personally delivered or if sent by
nationally-recognized overnight courier, by telecopy, or by registered or
certified mail, return receipt requested and postage prepaid, addressed as
follows:

If to the Company, to:

APP Pharmaceuticals

1501 East Woodfield Road, Suite 300 East

Schaumburg, Illinois 60173

Attn: James Callanan

If to the Executive, to:

The last home address the Company

maintains in its records for the Executive

Any such notice or communication shall be deemed to have been received: (A) in
the case of personal delivery, on the date of such delivery (or if such date is
not a business day, on the next business day after the date of delivery), (B) in
the case of nationally-recognized overnight courier, on the next business day
after the date sent, (C) in the case of telecopy transmission, when received (or
if not sent on a business day, on the next business day after the date sent) and
(D) in the case of mailing, on the third business day following that on which
the piece of mail containing such communication is posted.

(c) Validity; Severability. In the event that any one or more of the provisions
of this Agreement shall be held to be invalid, illegal or unenforceable for any
reason, the validity, legality and enforceability of the remainder of this
Agreement shall not in any way be affected or impaired thereby. Moreover,
without limiting the generality of the foregoing, if any one or more of the
provisions contained in this Agreement shall be held to be unreasonable or
unenforceable in any respect, including excessively broad as to duration, scope,
activity or subject, such provisions shall be construed by limiting and reducing
them so as to be enforceable to the maximum extent allowed by applicable law.

(d) Amendments and Waivers. This Agreement and any of the provisions hereof may
be amended, waived (either generally or in a particular instance and either
retroactively or prospectively), modified or supplemented, in whole or in part,
only by written agreement signed by the Parties hereto; provided, however, that
the observance of any provision of this Agreement may be waived in writing
signed by the Party that will lose the benefit of such provision as a result of
such waiver. The waiver by any Party hereto of a breach of any provision of this
Agreement shall not operate or be construed as a further or continuing waiver of
such breach or as a waiver of any other or subsequent breach, except as
otherwise specifically provided for in such waiver. Except as otherwise
expressly provided herein, no failure on the part of any Party to exercise, and
no delay in

 

- 11 -

--------------------------------------------------------------------------------

exercising, any right, power or remedy hereunder, or otherwise available in
respect hereof at law or in equity, shall operate as a waiver thereof, nor shall
any single or partial exercise of such right, power or remedy by such Party
preclude any other or further exercise thereof or the exercise of any right,
power or remedy.

(e) Cooperation. Following the termination of the Executive’s employment for any
reason, the Executive agrees to cooperate with the Company upon the Company’s
request and to be available to the Company with respect to matters arising out
of the Executive's services to the Company at reasonable times and places and
upon reasonable notice. The Company shall reimburse the Executive for expenses
reasonably incurred in connection with such matters as agreed by the Executive
and the Company in writing.

(f) Withholding. Notwithstanding any other provision of this Agreement, the
Company may withhold from any amounts payable or benefits provided under this
Agreement any federal, state, and local taxes as shall be required to be
withheld pursuant to any applicable law or regulation.

(g) Waiver; Strict Construction. Subject to the provisions of Section 8(d) the
Executive’s or the Company’s failure to insist upon strict compliance with any
provision of this Agreement or the failure to assert any right the Executive or
the Company may have hereunder, shall not be deemed to be a waiver of such
provision or right or any other provision or right of this Agreement.

(h) Entire Agreement; Effect on Prior Agreement. This Agreement shall constitute
the entire agreement between the Parties, and shall supersede all prior
representations, agreements and understandings (including any prior course of
dealings), both written and oral, between the Parties with respect to the
subject matter hereof and thereof.

(i) Counterparts. This Agreement may be executed in any number of counterparts,
each of which shall be deemed an original; but, all such counterparts shall
together constitute one and the same instrument.

(j) Binding Effect. This Agreement shall inure to the benefit of, and be binding
on, the successors and assigns of each of the Parties, including, without
limitation, the Executive’s heirs and the personal representatives of the
Executive’s estate and any successor to all or substantially all of the business
and/or assets of the Company whether by merger or otherwise (a “Successor”).

(k) No Third-Party Beneficiaries. Nothing in this Agreement shall confer upon
any Person not a party to this Agreement, or the legal representatives of such
Person, any rights or remedies of any nature or kind whatsoever under or by
reason of this Agreement.

Section 409A. If at the time the Executive becomes entitled to any severance
payments or any other termination payment from the Company (collectively
referred to as the “Severance”), the Executive is a “specified employee” (as
defined in Section 409A of

 

- 12 -

--------------------------------------------------------------------------------

the Internal Revenue Code of 1986, as amended and the regulations thereunder
(“Section 409A”)), then no Severance considered deferred compensation under
Section 409A and not subject to an exception or exemption thereunder shall be
paid to the Executive until the date that is six (6) months after the
Executive’s date of termination (or, if later, six (6) months after the
Executive has incurred a “separation from service” as defined in Section 409A).
For purposes of determining whether Severance payable on payroll dates occurring
on or prior to March 15 of the year following the year that includes the date of
termination are exempt from Section 409A as short-term deferrals, each Severance
payment shall be considered a separate payment for purposes of Section 409A. Any
Severance that would otherwise have been paid to the Executive during this
six-month period that is not exempt from Section 409A shall instead be
aggregated and paid to the Executive on the date that is six (6) months after
the Executive’s date of termination. Any Severance to which the Executive is
entitled to be paid after the date that is six (6) months following the
Executive’s date of termination or separation from service, as applicable, shall
be paid to the Executive in accordance with the applicable schedule. It is
intended that this Agreement will comply with Section 409A to the extent
applicable, and this Agreement shall be interpreted and construed on a basis
consistent with such intent.

The Company and the Executive agree to amend (including retroactively) this
Agreement in order to comply with Section 409A, including amending to facilitate
the ability of the Executive to avoid the imposition of, or reduce the amount
of, any Section 409A tax or penalties; to the extent that any such amendment
will, under Section 409A, have the intended effect. Notwithstanding the
foregoing, in the event that any payment, benefit, or distribution to or for the
benefit of the Executive, whether paid, payable, provided, distributed or
distributable pursuant to the terms of this Agreement or otherwise, (a
“Payment”) would be subject to the penalty taxes imposed by Section 409A or any
interest or penalties with respect to such penalty tax (such penalty tax,
together with any such interest or penalties, are hereinafter referred to as the
“409A Tax”), the Company shall pay to the Executive an additional payment (a
“Section 409A Gross-Up Payment”) in an amount such that after payment by the
Executive of all taxes (including any interest or penalties with respect to such
taxes), the Executive retains an amount of the Section 409A Gross-Up Payment
equal to the 409A Tax imposed upon the Payment. Any Section 409A Gross-Up
Payment shall be paid by the Company to the Executive in a lump sum within
thirty (30) days after the Executive remits the 409A Tax to the relevant taxing
authority. The Company and the Executive shall reasonably cooperate to provide
full effect to this provision and the consent to any amendment described in this
subsection shall not be unreasonably withheld by either party.

9. Indemnification. The Executive will be covered by the officer and director
insurance program of the Fresenius SE group and entitled to indemnification to
the fullest extent under the Amended and Restated By-Laws of Fresenius Kabi
Pharmaceuticals Holding, Inc. dated September 10, 2008 (or as those by-laws are
amended thereafter), Nothing in this Agreement, however, will require the
Company to provide indemnification in any situation where indemnification would
violate any applicable law.

10. Attorneys’ Fees. In any action or proceeding which either party brings
against the other to enforce its rights hereunder, the non-prevailing party
shall pay all costs incurred by the prevailing party, including reasonable
attorneys’ fees, which amounts shall be a part of the judgment in said action or
proceeding

[Remainder of page intentionally left blank]

 

- 13 -

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, the Executive has hereunto set the Executive’s hand and,
pursuant to the authorization from the Board of Management of Fresenius Kabi AG,
the Company has caused these presents to be executed in its name and on its
behalf, all as of the day and year first above written.

 

APP PHARMACEUTICALS, INC. By:  

/s/    Thomas Silberg

Name:   Thomas Silberg, CEO

 

Agreed and Accepted:

/s/    Richard Maroun

Richard Maroun

 

- 14 -

--------------------------------------------------------------------------------

EXHIBIT A

Company EBITDA Targets

 

EBITDA

(Millions)

  

Cash Bonus Award

0

   0

20

   20,000

50

   60,000

100

   120,000

200

   180,000

300

   240,000

400

   320,000

450

   400,000

500

   480,000

550

   540,000

600

   600,000

650

   660,000

700

   700,000

750

   740,000

800

   780,000

In the event EBITDA falls between the amounts set forth above, the Cash Bonus
shall be determined based upon straight-line interpolation. For example, if
EBITDA is $350 million, the Cash Bonus Award shall be $280,000, which
corresponds to the fact that $350 million is one half of the way between the
$300 million, and $400 million EBITDA amounts set forth above.

 

- 15 -

--------------------------------------------------------------------------------

Schedule 3(a)(iii)

1. Board of Trustees Alliant International University

 

- 16 -